| Stage | SHOE | % of rev | OSPN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $284M | 100.00% | $64M | 100.00% | SHOE ×4.45 |
| Gross profit | $91M | 31.87% | $49M | 76.29% | OSPN +44.4pp |
| Operating income | $8M | 2.68% | $9M | 14.47% | OSPN +11.8pp |
| Pre-tax income | $9M | 3.00% | $9M | 14.80% | OSPN +11.8pp |
| Net income | $6M | 2.20% | $8M | 12.21% | OSPN +10.0pp |
| Stage | SHOE | OSPN | Gap · A − B |
|---|---|---|---|
| Revenue | $284M100.00% | $64M100.00% | SHOE ×4.45 |
| Gross profit | 31.87%$91M | 76.29%$49M | OSPN +44.4pp |
| Operating income | 2.68%$8M | 14.47%$9M | OSPN +11.8pp |
| Pre-tax income | 3.00%$9M | 14.80%$9M | OSPN +11.8pp |
| Net income |
| 2.20%$6M |
| 12.21%$8M |
| OSPN +10.0pp |
No disclosed counterparties: SHOE, OSPN.